SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-24-006287
Filing Date
2024-04-30
Accepted
2024-04-30 17:09:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20240430xs3.htm S-3 230404
2 EX-5.1 tmb-20240430xex5d1.htm EX-5.1 10288
3 EX-23.1 tmb-20240430xex23d1.htm EX-23.1 2529
4 EX-FILING FEES tmb-20240430xexfees.htm EX-FILING FEES 41247
5 GRAPHIC tmb-20240430xex5d1001.jpg GRAPHIC 2144
6 GRAPHIC tmb-20240430xex5d1003.jpg GRAPHIC 10011
7 GRAPHIC tmb-20240430xex5d1004.jpg GRAPHIC 2634
8 GRAPHIC tmb-20240430xs3006.jpg GRAPHIC 10325
  Complete submission text file 0001558370-24-006287.txt   320675
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279015 | Film No.: 24898439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)